IP Library Granted Patent US 7,125,882
Granted Patent B2
US 7,125,882 · App. 10/768,769 · Granted Oct 24, 2006

Treatment of acne using alkonolamine compositions

Assignee: Union Bank of California, N.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,882
App. No.
10/768,769
Granted
Oct 24, 2006
Kind
B2
Abstract

Acne is treated or prevented by the topical application of compositions containing an alkanolamine such as dimethylaminoethanol, tyrosine, and a sulfur ingredient such as lipoic acid or glutathione. Adjunct ingredients such as fatty acid esters of ascorbic acid, e.g., ascorbyl palmitate and α-hydroxy acids may be included in the formulations. Compositions of the invention may be used alone, or, in many preferable embodiments, in combination with conventional acne medications such as anti-acne products containing salicylic acid, benzoyl peroxide, or a retinoid. In these embodiments, alkanolamine compositions of the invention are applied to affected skin areas first, and then a conventional acne medication is applied. This maximizes the efficacy of the treatment while minimizing skin irritation caused by conventional medications.

Claims (17)

1. A method for treating acne comprising applying to skin affected by acne, a composition consisting of:

a) from about 0.1% to about 10% by weight of an alkanolamine of the formula

wherein X, Y and Z are selected from the group consisting of hydrogen, C 1 –C 3 alkyl groups, C 2 –C 4 alkanol group, wherein at least one of X, Y, or Z is a C 2 –C 4 alkanol group bearing at least one hydroxyl group and optionally at least one carboxyl group;

b) from about 0.01% to about 6% by weight tyrosine;

c) from about 0.5% to about 15% by weight of a sulfur ingredient selected from the group consisting of lipoic acid, glutathione, sulfur, a combination of sulfur and resorcinol, a combination of sulfur and resorcinol monoacetate, sulfacetamide, and mixtures thereof;

d) a dermatologically acceptable carrier, and optionally, an adjunct ingredient selected from the group consisting an α-hydroxy acid, a fatty acid ester of ascorbic acid, and mixtures of any of these, wherein the composition acts upon the skin to treat acne.

2. A method according to claim 1 wherein the alkanolamine is selected from the group consisting of ethylaminoethanol, methylaminoethanol, dimethylaminoethanol, isopropanolamine, triethanolamine, isopropanoldimethylamine, ethylethanolamine, 2-butanolamine, choline, serine, and mixtures thereof, and the sulfur ingredient is lipoic acid, glutathione, or a mixture of lipoic acid and glutathione.

3. A method according to claim 2 wherein the alkanolamine is dimethylaminoethanol.

4. A method according to claim 3 wherein the composition consists of from about 0.03% to about 5% by weight dimethylaminoethanol, from about 0.03% to about 5% a by weight tyrosine, and from about 1% to about 10% by weight lipoic acid, glutathione, or a mixture of lipoic acid and glutathione.

5. A method according to claim 4 wherein the composition consists of from about 1% a to about 3% by weight dimethylaminoethanol, from about 0.2% to about 0.5% tyrosine, and from about 2% to about 10% lipoic acid, glutathione, or a mixture of lipoic acid and glutathione.

6. A method according to claim 1 wherein a conventional acne medication is applied to affected skin areas following administration of the alkanolamine composition.

7. A method according to claim 6 wherein in the conventional acne medication is salicylic acid.

8. A method according to claim 6 wherein in the conventional acne medication is tretinoin.

9. A method according to claim 6 wherein in the conventional acne medication is benzoyl peroxide.

10. A method according to claim 1 wherein a conventional medication is applied to affected skin areas before administration of the alkanolamine composition.

11. A method according to claim 1 wherein α-hydroxy acid is glycolic acid.

12. A method according to claim 1 wherein a fatty acid ester of ascorbic acid is ascorbyl palmitate.

Assignments (4)
SECURITY INTEREST Recorded Jun 5, 2015
From: N.V. PERRICONE LLC
To: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT
Reel/Frame 035833/0948 →
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2015
From: MUFG UNION BANK, N.A., AS AGENT FORMERLY KNOWN AS UNION BANK OF CALIFORNIA, N.A., AS AGENT
To: N.V. PERRICONE LLC
Reel/Frame 035835/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2007
From: PERRICONE, NICHOLAS V.
To: N. V. PERRICONE LLC
Reel/Frame 018837/0240 →
SECURITY AGREEMENT Recorded Mar 6, 2006
From: N.V. PERRICONE LLC
To: UNION BANK OF CALIFORNIA, N.A., AS AGENT FOR THE LENDERS
Reel/Frame 017251/0780 →
Continuity (3)
Continuation 1008586400 · Feb 27, 2002
Continuation In Part 0990068000 · Jul 6, 2001
Related Publication 20040185077A1 · Sep 23, 2004